Offc Action Outgoing

KERENDIA

Bayer Aktiengesellschaft

TRADEMARK REGISTRATION NO. 5518140 - KERENDIA - N/A

To: Bayer Aktiengesellschaft (bayertrademarkus@bayer.com)
Subject: TRADEMARK REGISTRATION NO. 5518140 - KERENDIA - N/A
Sent: 05/10/19 09:48:36 PM
Sent As: PRG@uspto.gov
Attachments:

UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO)

OFFICE ACTION (OFFICIAL LETTER) ABOUT OWNER’S TRADEMARK REGISTRATION

 

    U.S. REGISTRATION NO.           5518140

 

    OWNER:    Bayer Aktiengesellschaft

 

 

        

87700817

 

    CORRESPONDENT’S ADDRESS:

  Vanessa A. Ignacio

  One Lowenstein Drive

  lstrademark@lowenstein.com

  Roseland, NJ 07068

 

 

 

 

    MARK:       KERENDIA

 

 

 

    CORRESPONDENT’S REFERENCE/DOCKET NO.   N/A                

 

    CORRESPONDENT’S EMAIL ADDRESS: 

 bayertrademarkus@bayer.com

 

 

 

CLICK ON THE LINK BELOW TO RESPOND TO THIS LETTER AND SELECT FORM NUMBER 11:

 

 http://www.gov.uspto.report/trademarks/teas/reg_maintain.jsp

 

 

POST REGISTRATION OFFICE ACTION

 

 

ISSUE/MAILING DATE: 5/10/2019

U.S. Registration Number  5518140

 

The Section 7 Amendment submitted on April 25, 2019 is not accepted for the reasons set forth below.

 

The proposed amendment to the identification of goods and/or services cannot be accepted because it broadens the scope of the goods and/or services in the registration.  Such an amendment would require republication of the mark with the amended goods and/or services to ensure proper public notice as to the extent of the owner’s trademark rights.  The identification of goods and/or services in a registration can only be restricted or otherwise changed in ways that would not require republication of the mark.  37 C.F.R. §2.173(e); TMEP §1609.03.

 

The owner seeks to change the goods and/or services from “Veterinary pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis; (Based on 44(e)) Veterinary pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis” to “Pharmaceutical preparations for the treatment of renal, cardiovascular, ophthalmic, liver, pulmonary, metabolic, and vascular diseases and fibrosis except neurological and oncological diseases.”  Such an amendment would serve to broaden the scope to include goods and/or services not originally covered by the goods and/or services in the registration.  See In re Capp Enterprises, Inc., 32 USPQ2d 1855 (Comm’r Pats. 1993).  Accordingly, the Section 7 Amendment is not accepted.

 

The owner has six months from the issuance date of this letter to respond to all the issues raised in this letter.  In order to expedite the processing of your Section 7 Amendment, the early submission of a response to this letter is encouraged.  If a complete response is not received in the Office within this time period, then the Section 7 Amendment will be considered abandoned.  37 C.F.R. §2.176.  The fee for filing the Section 7 Amendment will not be refunded.

 

 

 

 

 

/Val Stevens/Trademark Specialist

Office of Post Registration

571-272-9228 (Office)

571-273-9228 (Fax)

val.stevens@uspto.gov

 

 

TO RESPOND TO THIS LETTER:  Use the Trademark Electronic Application System (TEAS) Response to Post-Registration Office action form number 11 at http://www.gov.uspto.report/trademarks/teas/reg_maintain.jsp.  Please wait 48-72 hours from the issue/mailing date before using TEAS, to allow for necessary system updates of the registration.  For technical assistance with online forms, e-mail TEAS@uspto.gov. For questions about the Office action itself, please contact the assigned specialist.  E-mail communications will not be accepted as responses to Office actions; therefore, do not respond to this Office action by e-mail.

 

All informal e-mail communications relevant to this registration will be placed in the official registration record.

 

WHO MUST SIGN THE RESPONSE:  It must be personally signed by an individual owner or someone with legal authority to bind an owner (i.e., a corporate officer, a general partner, all joint owners). If an owner is represented by an attorney, the attorney must sign the response.

 

CHECK THE STATUS OF THE REGISTRATION:  To check the status of your registration at any time, visit the Office’s Trademark Status and Document Retrieval (TSDR) system at http://tsdr.gov.uspto.report/. Please keep a copy of the TSDR status screen.  For more information on checking status, see http://www.gov.uspto.report/trademarks/process/status/.

 

TO UPDATE CORRESPONDENCE/E-MAIL ADDRESS:  Use the TEAS form at http://www.gov.uspto.report/trademarks/teas/correspondence.jsp.

 

 

 

 

TRADEMARK REGISTRATION NO. 5518140 - KERENDIA - N/A

To: Bayer Aktiengesellschaft (bayertrademarkus@bayer.com)
Subject: TRADEMARK REGISTRATION NO. 5518140 - KERENDIA - N/A
Sent: 05/10/19 09:48:36 PM
Sent As: PRG@uspto.gov
Attachments:





IMPORTANT NOTICE
USPTO OFFICE ACTION HAS ISSUED ON 05/10/2019 FOR
REGISTRATION NO. 5518140


Please follow the instructions below to continue the examination of your post registration filing:

VIEW OFFICE ACTION: Click on this link

http://tsdr.gov.uspto.report/view.action?DDA=Y&sn=87700817&type=OOA&date=20190510

(or copy and paste this URL into the address field of your browser), or visit http://tsdr.gov.uspto.report/ and enter the registration number to access the Office action.

PLEASE NOTE: The Office action may not be immediately available but will be viewable within 24 hours of this notification.

RESPONSE MAY BE REQUIRED: You should carefully review the Office action to determine (1) if a response is required, (2) how to respond and (3) the applicable response time period your response deadline will be calculated from.

Do NOT hit 'Reply' to this e-mail notification, or otherwise attempt to e-mail your response, as the USPTO does NOT accept e-mailed responses. Instead, the USPTO recommends that you respond online using the Trademark Electronic Application System response form at http://www.gov.uspto.report/teas/eTEASpageD.htm.

HELP: For technical assistance in accessing the Office action, please e-mail tsdr@uspto.gov. Please contact the assigned examiner with questions about the Office action.

WARNING


1. The USPTO will NOT send a separate e-mail with the Office action attached.

2. Failure to file any required response by the applicable deadline may result in the cancellation and/or expiration of your registration.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed